Hydrochloric Acid

Hydrochloric Acid

SCHEMBL40099

CCN=C=N.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4646 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12497426-B2 Rhamnolipid oligo-esters EVONIK OPERATIONS GMBH (DE) 2025-12-16 US claimed
EP-4658703-A1 BIODEGRADABLE COMPOUNDS, METHOD OF PREPARATION AND USE THEREOF Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860) (IN) 2025-12-10 EP claimed
EP-3419986-B1 RHAMNOLIPIDAMIDES FOR HAIR-PERFUME RETENTION EVONIK OPERATIONS GMBH (DE) 2025-11-05 EP claimed
CN-119736615-B Corrosion-resistant galvanized steel pipe and preparation process thereof 江苏智润管业有限公司 2025-06-10 CN claimed
CN-120025561-A Zein and dopamine graft and application thereof 广州医科大学 2025-05-23 CN claimed
EP-3419985-B1 RHAMNOLIPID ESTERS AS NON-IONIC SURFACTANTS FOR COSMETIC USE EVONIK OPERATIONS GMBH (DE) 2025-04-09 EP claimed
CN-119770455-A Nanometer drug delivery method for enhancing LGP kidney targeted release and application thereof 宜昌市中心人民医院(三峡大学第一临床医学院、三峡大学附属中心人民医院) 2025-04-08 CN claimed
CN-119736615-A Corrosion-resistant galvanized steel pipe and preparation process thereof 江苏智润管业有限公司 2025-04-01 CN claimed
CN-119633165-A Injection hydrogel wound dressing based on cross-linkable dextran 征鸿诺瓦医疗科技(深圳)有限公司 2025-03-18 CN claimed
CN-119504782-A Preparation and application of ferulic acid-biotin conjugate 成都理工大学 2025-02-25 CN claimed
CN-100387980-C Preparation method of polymer microflow control chip having metal microelectrode UNIV ZHEJIANG (CN) 2008-05-14 CN claimed
CN-1912190-A Method for conduction high polymer pattern sedimentation on surface of plastic JIANGSU TECHNOLOGY COLLEGE (CN) 2007-02-14 CN claimed
CN-1863553-A Polysaccharide-protein conjugate vaccines US GOV HEALTH & HUMAN SERV (US) 2006-11-15 CN claimed
CN-1725007-A Preparation method of polymer microflow control chip having metal microelectrode UNIV ZHEJIANG (CN) 2006-01-25 CN claimed
CN-1454994-A Affinity chromatography method of separating and purifying single-component earthworm plasminogen BIOPHYSICS INST CHINESE ACADEM (CN) 2003-11-12 CN claimed
EP-1189914-A1 DERIVATIVES OF 4'-DEMYCAROSYL-8a-AZA-8a-HOMOTYLOSIN PLIVA d.d. ZAGREB (HR) 2002-03-27 EP claimed
EP-1131281-A2 DERIVATISATION OF SUPPORT SURFACES Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2001-09-12 EP claimed
WO-2000077016-A1 DERIVATIVES OF 4'-DEMYCAROSYL-8a-AZA-8a-HOMOTYLOSIN PLIVA D.D. (SI) 2000-12-21 WO claimed
WO-2000029373-A2 DERIVATISATION OF SUPPORT SURFACES Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2000-05-25 WO claimed
WO-1995000177-A1 PHARMACEUTICAL PREPARATION AND A METHOD FOR INHIBITING THE REPLICATION OF VARIOUS VIRUSES DEXTRAN PRODUCTS LIMITED (CA) 1995-01-05 WO claimed